Showing 1781-1790 of 5643 results for "".
- Camras Vision Announces Completion of $5.7 Million Financing for Novel Glaucoma Devicehttps://modernod.com/news/camras-vision-announces-completion-of-5-7-million-financing-for-novel-glaucoma-device/2480215/Camras Vision has closed on $5.7 million in equity funding to be used to support four clinical trials globally, including a pilot study in the United States, to study the efficacy of the Camras device for the treatment of refractory glaucoma. The funding was made in its
- OraSure Technologies’ Spit Test for COVID-19 is Coming Closerhttps://modernod.com/news/bethlehem-firms-spit-test-for-covid-19-is-coming-closer/2477975/In the shadow of the hulking Bethlehem Steel foundry, whose long-idled smokestacks stand like tombstones for the defunct industrial giant, a Pennsylvania technology company is racing to “de
- Alcon to Showcase Latest Innovations at AAO 2024 Annual Meetinghttps://modernod.com/news/alcon-to-showcase-latest-innovations-at-aao-2024-annual-meeting/2482489/Alcon will unveil its latest clinical data and product innovations at the American Academy of Ophthalmology (AAO) 2024 annual meeting. Attendees, including ophthalmologists, surgical staff, researchers, and industry leaders, are invited to visit Alcon at booth #4008 for hands-on demonstrations an
- AI Can Identify Heart Disease From an Eye Scanhttps://modernod.com/news/ai-can-identify-heart-disease-from-an-eye-scan/2480602/Scientists have developed an artificial intelligence system that can analyze eye scans taken during a routine visit to an optician or eye clinic and identify patients at a high risk of a heart attack, according to a University of Leeds, UK, news release. Doctors have recognized th
- Kubota Vision Initiates PBOS Prospective Study in Patientshttps://modernod.com/news/kubota-vision-initiates-pbos-prospective-study-in-patients/2480577/Kubota Vision announced that on January 17, 2022, the first patient has enrolled and completed the first visit in a prospective study in Japan using the company's Patient Based Ophthalmology Suite (PBOS), in-home optical coherence tomography (OCT) device. The study is being led by S
- OneSight Partners With Anthem Blue Cross and Blue Shield Foundation to Provide Free Eye Exams and Glasses in Cincinnatihttps://modernod.com/news/onesight-partners-with-anthem-blue-cross-and-blue-shield-foundation-to-provide-free-eye-exams-and-glasses-in-cincinnati/2479049/Preventative care visits have dropped significantly over the course of the pandemic, and this is especially true in under-served communities. That’s why the Anthem Blue Cross and Blue Shield Foundation teamed up with OneSight, a leading global vision care nonprofit, to provide free eye exams and
- Graybug Vision Completes Treatment Phase of ALTISSIMO Trial in Wet AMD with 12-Month Topline Datahttps://modernod.com/news/graybug-vision-completes-treatment-phase-of-altissimo-trial-in-wet-amd-with-12-month-topline-data/2478738/Graybug Vision announced the last patient visit in its GB-102 phase 2b ALTISSIMO core trial (the 12-month treatment phase) in wet age-related macular degeneration (AMD). ALTISSIMO 12-month topline data are expected to be announced in the second quarter of 2021, with full results to b
- ASRS Releases Guidelines to Help Retina Practices Navigate COVID-19 Pandemichttps://modernod.com/news/asrs-releases-guidelines-to-help-retina-practices-navigate-covid-19-pandemic/2477427/The American Society of Retina Specialists (ASRS) has released detailed guidelines to help retina practices reduce risk and help assure the health and safety of patients and medical personnel during the COVID-19 pandemic. The guidelines define what constitutes an essential visit and provide a mea
- US Ophthalmologists Push to Remove Roadblocks to Patients’ Access to Medical and Surgical Eye Carehttps://modernod.com/news/us-ophthalmologists-push-to-remove-roadblocks-to-patients-access-to-medical-and-surgical-eye-care/2476461/More than 400 eye physicians and surgeons from across the United States are in Washington, DC, to urge Congress to end federal policies that delay patients’ access to quality medical and surgical eye care. As part of its annual visit to Capitol Hill, the American Academy of Ophthalmology (AAO) is
- LumiThera Obtains FDA Authorization of Valeda Treatment for Dry AMDhttps://modernod.com/news/lumithera-obtains-fda-authorization-of-valeda-treatment-for-dry-amd/2482525/The FDA has granted authorization to LumiThera allowing the company to market its Valeda Light Delivery System. This approval, made under the De Novo authorization pathway, makes Valeda the first FDA-authorized device to treat vision loss in patients with dry AMD.